We are live on ! Find out more
BSX icon

Boston Scientific

1,512 hedge funds and large institutions have $120B invested in Boston Scientific in 2024 Q4 according to their latest regulatory filings, with 218 funds opening new positions, 617 increasing their positions, 489 reducing their positions, and 83 closing their positions.

New
Increased
Maintained
Reduced
Closed

163% more first-time investments, than exits

New positions opened: 218 | Existing positions closed: 83

26% more repeat investments, than reductions

Existing positions increased: 617 | Existing positions reduced: 489

9% more capital invested

Capital invested by funds: $111B → $120B (+$9.45B)

8% more funds holding

Funds holding: 1,3951,512 (+117)

8% more funds holding in top 10

Funds holding in top 10: 3639 (+3)

1.08% more ownership

Funds ownership: 89.89%90.98% (+1.1%)

13% less call options, than puts

Call options by funds: $797M | Put options by funds: $912M

Holders
1,512
Holders Change
+117
Holders Change %
+8.39%
% of All Funds
19.92%
Holding in Top 10
39
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+8.33%
% of All Funds
0.51%
New
218
Increased
617
Reduced
489
Closed
83
Calls
$797M
Puts
$912M
Net Calls
-$115M
Net Calls Change
+$168M
Name Holding Trade Value Shares
Change
Change in
Stake
MSU
351
Mizuho Securities USA
New York
$12.5M +$3.89M +44,193 +46%
Pacer Advisors
352
Pacer Advisors
Pennsylvania
$12.3M +$2.18M +24,754 +22%
SC
353
Sapient Capital
Indiana
$12.1M +$84.9K +964 +0.7%
Lido Advisors
354
Lido Advisors
California
$12M +$1.15M +13,018 +11%
EMPI
355
Elo Mutual Pension Insurance
Finland
$12M -$470K -5,334 -4%
QCM
356
Quantinno Capital Management
New York
$12M +$3.79M +43,050 +47%
PF
357
Phoenix Financial
Israel
$12M -$3.96M -45,033 -25%
FAB
358
First American Bank
Illinois
$11.6M +$114K +1,299 +1%
GI
359
GAMCO Investors
Connecticut
$11.6M +$795K +9,035 +8%
Twin Tree Management
360
Twin Tree Management
Texas
$11.4M -$7.04M -79,930 -38%
LGF
361
LGT Group Foundation
Liechtenstein
$11.4M -$3.96M -44,974 -26%
OPERF
362
Oregon Public Employees Retirement Fund
Oregon
$11.3M +$31.7K +360 +0.3%
Pathstone Holdings
363
Pathstone Holdings
New Jersey
$11.3M +$146K +1,659 +1%
FNT
364
First National Trust
Pennsylvania
$10.8M -$203K -2,311 -2%
GAM
365
Generali Asset Management
Italy
$10.7M +$10.6M +120,344 New
Nordea Investment Management
366
Nordea Investment Management
Sweden
$10.7M +$664K +7,540 +7%
TI
367
Tidal Investments
Wisconsin
$10.7M +$2.94M +33,369 +39%
SSA
368
Sierra Summit Advisors
Nevada
$10.6M +$716K +8,135 +7%
GC
369
Guggenheim Capital
Illinois
$10.6M +$606K +6,882 +6%
BIC
370
Beach Investment Counsel
Pennsylvania
$10.4M -$4.22M -47,946 -29%
EAM
371
EdenTree Asset Management
United Kingdom
$10.3M -$141K -1,600 -1%
PFM
372
Premier Fund Managers
United Kingdom
$10.3M -$1.2M -13,600 -11%
OAM
373
Oppenheimer Asset Management
New York
$10.2M +$17.3K +196 +0.2%
Wealthfront Advisers
374
Wealthfront Advisers
California
$10.2M +$646K +7,338 +7%
RS
375
Robeco Schweiz
Switzerland
$10.2M -$4.94M -56,107 -33%

BSX Hedge Fund Activity: Q4 2024 in Review

1,512 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2024, worth a combined $120B — up 8.5% from $111B a quarter earlier.

Buyers outnumbered sellers: 218 funds opened new BSX positions and 83 closed out — a net gain of 135 holders — while 617 added to existing stakes and 489 trimmed.

The largest buyer was BlackRock, adding an estimated $909M. The largest seller was Massachusetts Financial Services, cutting an estimated $529M.

  • 1,512 institutional investors held Boston Scientific (BSX) as of Q4 2024, up from 1,395 in Q3 2024.
  • Funds reported $120B of Boston Scientific stock for Q4 2024, up 8.5% quarter-over-quarter.
  • 218 funds opened new Boston Scientific positions in Q4 2024 and 83 closed out, a net change of +135 holders.
  • The largest Boston Scientific buyer in Q4 2024 was BlackRock, an estimated $909M added.
  • The largest Boston Scientific seller in Q4 2024 was Massachusetts Financial Services, an estimated $529M sold.

Based on aggregated 13F filings for Q4 2024.